» Articles » PMID: 26330839

Human Umbilical Cord Blood Stem Cells and Brain-derived Neurotrophic Factor for Optic Nerve Injury: a Biomechanical Evaluation

Overview
Date 2015 Sep 3
PMID 26330839
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Treatment for optic nerve injury by brain-derived neurotrophic factor or the transplantation of human umbilical cord blood stem cells has gained progress, but analysis by biomechanical indicators is rare. Rabbit models of optic nerve injury were established by a clamp. At 7 days after injury, the vitreous body received a one-time injection of 50 μg brain-derived neurotrophic factor or 1 × 10(6) human umbilical cord blood stem cells. After 30 days, the maximum load, maximum stress, maximum strain, elastic limit load, elastic limit stress, and elastic limit strain had clearly improved in rabbit models of optical nerve injury after treatment with brain-derived neurotrophic factor or human umbilical cord blood stem cells. The damage to the ultrastructure of the optic nerve had also been reduced. These findings suggest that human umbilical cord blood stem cells and brain-derived neurotrophic factor effectively repair the injured optical nerve, improve biomechanical properties, and contribute to the recovery after injury.

Citing Articles

Lipid-based nanoparticles for drug delivery in Parkinson's disease.

Cai H, Liu D, Xue W, Ma L, Xie H, Ning K Transl Neurosci. 2024; 15(1):20220359.

PMID: 39654878 PMC: 11627081. DOI: 10.1515/tnsci-2022-0359.


Stem cell therapy in ocular pathologies in the past 20 years.

Miotti G, Parodi P, Zeppieri M World J Stem Cells. 2021; 13(5):366-385.

PMID: 34136071 PMC: 8176844. DOI: 10.4252/wjsc.v13.i5.366.


Mechanical properties of the sciatic nerve following combined transplantation of analytically extracted acellular allogeneic nerve and adipose-derived mesenchymal stem cells.

Piao C, Li Z, Ding J, Kong D Acta Cir Bras. 2020; 35(4):e202000405.

PMID: 32555937 PMC: 7292625. DOI: 10.1590/s0102-865020200040000005.


Umbilical Cord Blood and Serum for the Treatment of Ocular Diseases: A Comprehensive Review.

Giannaccare G, Carnevali A, Senni C, Logozzo L, Scorcia V Ophthalmol Ther. 2020; 9(2):235-248.

PMID: 32107737 PMC: 7196109. DOI: 10.1007/s40123-020-00239-9.


Acellular allogeneic nerve grafting combined with bone marrow mesenchymal stem cell transplantation for the repair of long-segment sciatic nerve defects: biomechanics and validation of mathematical models.

Li Y, Zhao B, Lv H, Qin Z, Luo M Neural Regen Res. 2016; 11(8):1322-6.

PMID: 27651781 PMC: 5020832. DOI: 10.4103/1673-5374.189198.


References
1.
Tsai R, Chang C, Sheu M, Huang Z . Anti-apoptotic effects of human granulocyte colony-stimulating factor (G-CSF) on retinal ganglion cells after optic nerve crush are PI3K/AKT-dependent. Exp Eye Res. 2010; 90(5):537-45. DOI: 10.1016/j.exer.2010.01.004. View

2.
Pascolini D, Mariotti S . Global estimates of visual impairment: 2010. Br J Ophthalmol. 2011; 96(5):614-8. DOI: 10.1136/bjophthalmol-2011-300539. View

3.
Zhao T, Li Y, Tang L, Li Y, Fan F, Jiang B . Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats. Graefes Arch Clin Exp Ophthalmol. 2011; 249(7):1021-8. DOI: 10.1007/s00417-011-1635-7. View

4.
Jiang Y, Xu H, Liu J, Li P, Wu Y . Biomechanical analysis of optic nerve injury treated by compound light granules and ciliary neurotrophic factor. Neural Regen Res. 2014; 7(36):2889-900. PMC: 4190947. DOI: 10.3969/j.issn.1673-5374.2012.36.006. View

5.
Sui X, Sun J, Li L, Zhou C, Luo X, Xia N . Evaluation of a MEMS-based dual metal-layer thin-film microelectrode array for suprachoroidal electrical stimulation. IEEE Trans Neural Syst Rehabil Eng. 2012; 21(4):524-31. DOI: 10.1109/TNSRE.2012.2188042. View